- Home
- OCGN vs FET Comparison
OCGN vs FET Comparison
Compare OCGN & FET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- FET
- Stock Information
- Founded
- OCGN 2013
- FET 2005
- Country
- OCGN United States
- FET United States
- Employees
- OCGN N/A
- FET N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- FET Metal Fabrications
- Sector
- OCGN Health Care
- FET Industrials
- Exchange
- OCGN Nasdaq
- FET Nasdaq
- Market Cap
- OCGN 189.6M
- FET 177.1M
- IPO Year
- OCGN N/A
- FET 2012
- Fundamental
- Price
- OCGN $0.68
- FET $15.45
- Analyst Decision
- OCGN Strong Buy
- FET
- Analyst Count
- OCGN 3
- FET 0
- Target Price
- OCGN $6.33
- FET N/A
- AVG Volume (30 Days)
- OCGN 4.3M
- FET 92.9K
- Earning Date
- OCGN 05-13-2025
- FET 05-01-2025
- Dividend Yield
- OCGN N/A
- FET N/A
- EPS Growth
- OCGN N/A
- FET N/A
- EPS
- OCGN N/A
- FET N/A
- Revenue
- OCGN $4,054,999.00
- FET $816,425,000.00
- Revenue This Year
- OCGN N/A
- FET N/A
- Revenue Next Year
- OCGN N/A
- FET $1.24
- P/E Ratio
- OCGN N/A
- FET N/A
- Revenue Growth
- OCGN N/A
- FET 10.50
- 52 Week Low
- OCGN $0.52
- FET $12.78
- 52 Week High
- OCGN $2.06
- FET $21.57
- Technical
- Relative Strength Index (RSI)
- OCGN 51.84
- FET 42.53
- Support Level
- OCGN $0.64
- FET $13.34
- Resistance Level
- OCGN $0.74
- FET $15.65
- Average True Range (ATR)
- OCGN 0.07
- FET 1.40
- MACD
- OCGN 0.00
- FET -0.28
- Stochastic Oscillator
- OCGN 54.50
- FET 32.09
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About FET Forum Energy Technologies Inc.
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.